Position in CYTK
as of Jun 30, 2026
· filed Jul 23, 2026
Position Value
$22,149
+$4,881 QoQ
Shares Held
260
-0.8% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#399
of 477 holders
Holding Since
Jun 2023
11 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in CYTK Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026AdvisorNet Financial, Inc holds $3,788,127 across 40 Biotechnology names. CYTK ranks #18 (0.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
3,349 | $1,663,548 | |
| 2 | CRSP |
CRISPR Therapeutics AG
|
8,503 | $463,753 | |
| 3 | INCY |
Incyte Corp
|
3,022 | $342,573 | |
| 4 | NAMS |
NewAmsterdam Pharma Co N.V.
|
8,375 | $283,828 | |
| 5 | TECH |
BIO-TECHNE Corp
|
3,051 | $215,553 | |
| 6 | REGN |
Regeneron Pharmaceuticals, Inc.
|
219 | $136,555 | |
| 7 | RVMD |
Revolution Medicines, Inc.
|
524 | $98,134 | |
| 8 | TGTX |
Tg Therapeutics, Inc.
|
1,620 | $89,002 |
All Filings in CYTK
Export CSV
11 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $22,149 | 260 | Shares | Sole | 2026-07-23 | |
| 2026-03-31 | $17,268 | 262 | Shares | Sole | 2026-04-17 | |
| 2025-12-31 | $19,760 | 311 | Shares | Sole | 2026-01-20 | |
| 2025-09-30 | $13,849 | 252 | Shares | Sole | 2025-10-09 | |
| 2025-06-30 | $9,019 | 273 | Shares | Sole | 2025-07-14 | |
| 2025-03-31 | $924 | 23 | Shares | Sole | 2025-04-07 | |
| 2024-12-31 | $1,270 | 27 | Shares | Sole | 2025-01-13 | |
| 2024-09-30 | $1,108 | 21 | Shares | Sole | 2024-10-15 | |
| 2023-12-31 | $250 | 3 | Shares | Sole | 2024-01-19 | |
| 2023-09-30 | $88 | 3 | Shares | Sole | 2023-10-12 | |
| 2023-06-30 | $97 | 3 | Shares | Sole | 2023-07-14 | |
| No filing history on record for this holder in this stock. | ||||||